Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin use--an historical review.

R S Griffith

    The Journal of Antimicrobial Chemotherapy
    |December 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Vancomycin, an antibiotic discovered in the 1950s, combats resistant Staphylococcus aureus infections. Its use has increased due to rising antibiotic resistance, making it crucial for treating severe bacterial infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparison of oral penicillin V with injectable procaine penicillin.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    A positive, systematic approach to improve inpatient medical record completion in a family practice residency program.

    Family medicine·1996
    Same author

    Barriers and incentives of physicians and patients to cancer screening.

    Primary care·1992
    Same author

    Preoperative evaluation. Medical obstacles to surgery.

    Cancer·1992
    Same author

    Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis.

    Dermatologica·1987
    Same author

    Pharmacology of erythromycin in adults.

    Pediatric infectious disease·1986

    Area of Science:

    • Microbiology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Rising antibiotic resistance in Staphylococcus aureus necessitated novel therapeutic agents in the 1950s.
    • Screening programs identified microorganisms with antimicrobial properties to combat resistant bacterial strains.

    Observation:

    • A microorganism, Streptomyces orientalis, isolated from Borneo, produced vancomycin.
    • Vancomycin demonstrated significant antistaphylococcal activity and a favorable safety profile in initial patient studies.

    Findings:

    • Vancomycin effectively treats Staphylococcus aureus infections, including those resistant to other antibiotics.
    • Its clinical utility has expanded to include prophylaxis in dialysis patients and treatment of enterocolitis.

    Related Experiment Videos

    Implications:

    • Vancomycin remains a critical antibiotic for managing serious infections, especially with increasing antimicrobial resistance.
    • The discovery highlights the importance of microbial natural products in drug development for infectious diseases.